Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,663 across all filing types
Latest filing 2025-11-05 Share Issue/Capital Cha…
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - AVR 7 pages 21.6KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and contains detailed information about the issuance of unquoted securities, including warrants, their quantities, issue dates, and terms. It references previous announcements (Appendix 3B) related to securities issuance and provides specifics about the securities issued, their exercise prices, and expiry dates. The document is a formal notification to the ASX about securities issuance rather than a financial report or earnings release. This fits the category of Share Issue/Capital Change announcements, which cover new share issues or capital changes. The document length (7708 characters) and content confirm it is a detailed notification rather than a brief announcement or a report publication notice.
2025-11-05 English
Cleansing Notice 2 pages 205.6KB
Capital/Financing Update Classification · 95% confidence The document is a Cleansing Notice under Section 708A(5)(e) of the Corporations Act 2001 (Cth), which relates to the issuance of shares without disclosure under certain conditions. It announces the issuance of shares as part of a capital raising and compliance with relevant sections of the Corporations Act. The document is short (3945 characters) and serves as a formal announcement of a capital raising event and related regulatory compliance, rather than a full financial report or detailed capital structure update. This fits the category of a Capital/Financing Update (CAP) because it provides information about the company's fundraising activity and share issuance. It is not an Annual Report, Interim Report, or Regulatory Filing in the sense of officer certifications or miscellaneous filings. Therefore, the appropriate classification is CAP with high confidence.
2025-11-05 English
8-K
Regulatory Filings
2025-11-03 English
FDA Approves DurAVR THV Global Pivotal Trial 2 pages 225.3KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing FDA approval to initiate a global clinical trial (the PARADIGM Trial) for a medical device (DurAVR Transcatheter Heart Valve). It describes the trial design, objectives, and regulatory context but does not contain financial data, earnings, or management discussion. It is not an annual or interim report, earnings release, or regulatory filing of financial results. It is an announcement related to clinical trial initiation and regulatory approval, which does not fit into financial report categories. The document is a regulatory announcement about a clinical trial approval and initiation, best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2025-11-02 English
Update on Capital Raising Timetable 2 pages 245.2KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Update on Capital Raising Timetable' and provides a revised indicative timetable for the Australian Offer component of a capital raising previously announced. It includes specific dates for settlement and allotment of new securities, and mentions the ASX and NASDAQ listings. The content focuses on the timing and procedural update of a capital raising event rather than the full details of the capital raising itself or financial results. The document length is 4213 characters, which is relatively short and consistent with an announcement rather than a full report. There is no detailed financial data or comprehensive analysis present. Therefore, this document fits best under the category of Capital/Financing Update (CAP).
2025-11-02 English
Notification of cessation of securities - AVR 4 pages 14.8KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation of certain securities (options) for Anteris Technologies Global Corp. It includes specific information about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is a formal announcement related to changes in the company's issued capital securities, specifically the cessation of certain options. This fits the category of Share Issue/Capital Change announcements, which cover new share issues, stock splits, or other capital changes such as cessation of securities. The document length is 3837 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2025-11-02 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.